CD4 and cancer: In comparison to CD4+ T cells restimulated polyclonally in the absence of cancer cells, we found a profoundly greater increase in the production of PD-1 and PD-L1 proteins in CD4+ T cells restimulated in the presence of cancer cells (Figure 3D–F).